Gold nanoparticles capped by an unsymmetrical azobenzene disulfide, 4-hexyl-4‘-(12-(dodecyldithio)dodecyloxy)azobenzene (C6AzSSC12), were synthesized in order to investigate
the efficiency of azobenzene photoisomerization on colloidal gold surfaces. The nanoparticles
were synthesized by a two-step method to avoid the direct contact of azobenzene units with
a reducing agent. The average size of the particles was determined to be ∼5.2 ± 1.3 nm
from transmission electron microscope (TEM) images. The CH2 antisymmetric (∼2919 cm-1)
and symmetric (∼2850 cm-1) stretching bands in the FTIR spectra of the nanocomposite
confirmed the all-trans conformation of alkyl chains in the C6AzSSC12 on the colloidal gold.
The photoisomerization reaction of the C6AzSSC12-capped gold nanoparticles was studied
by UV−vis absorption spectroscopy in toluene. The reaction kinetics was identical to that of
the free C6AzSSC12 molecules dissolved in toluene, with no deviations from a first-order
plot for both trans-to-cis and cis-to-trans photoisomerization, suggesting no steric hindrance
throughout the whole reaction process. The free volume guaranteed by the 50% dilution of
the dye functions due to the unsymmetrical disulfide structures, as well as their noncompact
molecular tails owing to the assembly on the curved colloidal gold, must be responsible for
such a highly efficient photoreaction. Sedimentation of the nanoparticles arose in toluene
subsequent to the photoisomerization of the capping azobenzene molecules from trans to
cis isomers. This phenomenon can be interpreted as resulting from differences in the degree
of solvation between the azobenzene isomers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.